These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 30416015)
1. Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series. Arthur L; Keen K; Verriotis M; Peters J; Kelly A; Howard RF; Dib-Hajj SD; Waxman SG; Walker SM J Pediatr; 2019 Mar; 206():217-224.e9. PubMed ID: 30416015 [TBL] [Abstract][Full Text] [Related]
2. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile. McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677 [TBL] [Abstract][Full Text] [Related]
3. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7. Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532 [TBL] [Abstract][Full Text] [Related]
4. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia. Klein CJ; Wu Y; Kilfoyle DH; Sandroni P; Davis MD; Gavrilova RH; Low PA; Dyck PJ J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):386-91. PubMed ID: 23129781 [TBL] [Abstract][Full Text] [Related]
8. Mutation in Na Haehner A; Hummel T; Heinritz W; Krueger S; Meinhardt M; Whitcroft KL; Sabatowski R; Gossrau G Eur J Pain; 2018 Nov; 22(10):1767-1773. PubMed ID: 29934995 [TBL] [Abstract][Full Text] [Related]
9. Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7). Deuis JR; Kumble S; Keramidas A; Ragnarsson L; Simons C; Pais L; White SM; Vetter I Hum Mol Genet; 2024 Jan; 33(2):103-109. PubMed ID: 37721535 [TBL] [Abstract][Full Text] [Related]
10. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli. Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160 [TBL] [Abstract][Full Text] [Related]
11. A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers. Wu MT; Huang PY; Yen CT; Chen CC; Lee MJ PLoS One; 2013; 8(1):e55212. PubMed ID: 23383113 [TBL] [Abstract][Full Text] [Related]
12. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder. Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323 [TBL] [Abstract][Full Text] [Related]
13. Bilateral congenital corneal anesthesia in a patient with SCN9A mutation, confirmed primary erythromelalgia, and paroxysmal extreme pain disorder. Kim DT; Rossignol E; Najem K; Ospina LH J AAPOS; 2015 Oct; 19(5):478-9. PubMed ID: 26486037 [TBL] [Abstract][Full Text] [Related]
14. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations. Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865 [No Abstract] [Full Text] [Related]
15. Autonomic dysfunction in SCN9A-associated primary erythromelalgia. Kim MK; Yuk JW; Kim HS; Park KJ; Kim DS Clin Auton Res; 2013 Apr; 23(2):105-7. PubMed ID: 23152140 [TBL] [Abstract][Full Text] [Related]
16. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia. Cregg R; Laguda B; Werdehausen R; Cox JJ; Linley JE; Ramirez JD; Bodi I; Markiewicz M; Howell KJ; Chen YC; Agnew K; Houlden H; Lunn MP; Bennett DL; Wood JN; Kinali M Neuromolecular Med; 2013 Jun; 15(2):265-78. PubMed ID: 23292638 [TBL] [Abstract][Full Text] [Related]
17. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391 [TBL] [Abstract][Full Text] [Related]